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Abstract
The aim of our study was to evaluate the antidiabetic and hepatoprotective efficacy of dry extract from bearberry leaves 
enriched with arginine in dexamethasone induced IR.
Materials and methods. IR was induced in rats by low dose intraperitoneally injections of dexamethasone. Dexametha-
sone-induced IR in rats was treated by bearberry leaves extract enriched with arginine. Thus, animals were randomized into several 
groups including intact animals and animals, which administered reference compounds and medications.
The activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamine transferase (GGT) 
were determined in blood serum and liver homogenate, in addition, in blood serum we measured lactate dehydrogenase (LDH) 
activity and lactate level and glycogen content liver tissue. Also, for the purpose of our experiment, in liver tissue were determined: 
thiobarbituric acid reactive substances (TBARS), diene conjugates (DC), and reduced glutathione (GSH) content; and superoxide 
dismutase (SOD), glutathione peroxidase (Gpx), and catalase (CAT) activities. All indices were determined using generally accepted 
unified methods or commercially available kits. 
Results. Long-term dexamethasone administration led to an increase in AST, ALT and GGT overall activity in the liver 
homo genate and serum; this could be the result of increased permeability of hepatocyte plasma membranes, as well as their enhanced 
synthesis in the liver. Studied extract ameliorate these indices of liver injury. Evaluation of indices that reflected oxidative stress and 
the antioxidant system status in liver confirmed oxidative stress development in IR rats’ liver. Administration of arginine enriched 
bearberry leaves extract decrease TBARS and DC content in liver tissue, at the same time, improve SOD, Gpx, and CAT activities 
and increase GSH content.
Conclusions. Bearberry leaves dry extract enriched with arginine inhibit oxidative stress development, improve membrane 
integrity, and normalize some indices of carbohydrate metabolism, particularly glycogen content in liver and lactate level in blood.
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1. Introduction
The prevalence of patients with diabetes mellitus type 2 (DM2) is rising dramatically all 
over the world. According to the World Health Organization, by 2025 the number of diabetic pa-
tients is expected to reach 334 million [1]. DM2 is a serious medical and social problem that must 
attract the attention of medical workers of all specialties and qualifications, not only because this 
disease is highly abundant, but also due to a large number of complications. DM2, which is the 
sixth leading cause of death in the world [2], is based on the development of insulin resistance (IR) 
and relative insulin deficiency. One of the causes of death associated with type DM2 is liver disease. 
The DM2 development negatively affects the hepatocyte metabolism, disrupting the pathways of 
carbohydrates, amino acids, lipids and other compounds, which, in turn, leads to liver function 
disorders. Numerous studies revealed the existence of hepatic and systemic oxidative stress [3], 
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and, apparently, hyperglycemia is a driving factor in increased reactive oxygen species (ROS) 
production and can activate pathways of glucose autooxidation, protein glycation, and subsequent 
oxidative breakdown of glycated proteins [4].
Despite the significant progress achieved in the study of DM2 pathogenesis and, thereafter, 
its treatment, the investigation and development of new medications aimed for the correction and 
prevention of DM2, and its complications continues to be one of the most needful issues in medical 
practice [5]. Thereby, our attention was focused on the Family Ericaceae as source of novel anti- 
diabetic medications, particularly, the bearberry leaves (Arctostaphylos uva-ursi L). The phyto-
chemical study of the obtained extract determined such biologically active substances included in 
its composition as phenol glycoside, phenol carboxylic acid and flavonoids [6].
The present study was aimed to evaluate the antidiabetic and hepatoprotective efficacy of 
dry extract from bearberry leaves enriched with arginine in dexamethasone induced IR.
2. Materials and methods
In experiments we used dry 50 % alcohol extract from bearberry leaves enriched with 
arginine (PE50_arg), which was developed and obtained at the National University of Pharma-
cy (NUPh) Parmacognosy Department under prof. Oleh Koshovyi supervision [7].
Male adult outbred albino rats were obtained and kept in vivarium of Educational and Scien-
tific Institute of Applied Pharmacy NUPh with standard show and free access to water. IR was in-
duced by low dose long-term intraperitoneally injections of dexamethasone (dex, KRKA, Slovenia) 
in dose 15 mkg/kg b. w. for 7 weeks [8]. Dexamethasone-induced IR rats were treated by bearberry 
leaves 50 % alcohol extract (PE50) and PE50_arg for a period of 14 days in dose of 100 mg/kg b. w. 
and, clearly, the same period other groups of animals were administered the reference medications 
metformin in dose 100 mg/kg b. w. (Teva Pharmaceutical Industries Ltd, Poland) and «Arphasetin» 
infusion in dose18 ml/kg b. w. («Liktravy», Ukraine). Thus, 42 rats, 6 animals in each group, were 
randomized into 7 groups: 1 – intact animals (IC); 2 – animals with dexamethasone induced IR (Dex); 
3 – IR animals were treated with PE50 (Dex_PE50); 4 – IR animals were treated with 
PE50_arg (Dex_PE50_arg); 5 – IR animals were administered with L-arginine solution (Sigma- 
Aldrich, Germany) at a dose of 200 mg/kg b. w. (Dex_arg); 6 – IR animals were treated with «Ar-
phasetin» infusion and 7 – IR animals were treated with metformin.
At the end of the 7th week of experiment the animals, which were fasted overnight, were 
sacrificed by decapitation and blood samples were taken to prepare blood serum. The liver from 
each rat, after perfusion by cooled saline, was weighed and the samples were homogenized in 
0.1 M Tris HCl buffer 7.4 for determination of enzyme activities. Another portion of wet liver – was 
used for the estimation of glycogen content.
In order to evaluate liver damage and function, the activity of alanine aminotransferase (ALT), 
aspartate aminotransferase (AST), gamma-glutamine transpeptidase (GGT) in blood serum and 
liver homogenate was determined using commercially available kits (NPP Felicit-Diagnostics, 
Ukraine), as well as, in blood serum we measured lactate dehydrogenase (LDH) activity and lactate 
level with the help of commercial kits (NPP «Laboratory Granum», Ukraine) and glycogen content 
with anthrone reagent in liver tissue [9]. Also, for the purpose of our experiment, in liver tissue were 
determined indices that reflected oxidative stress development and the antioxidant system status 
using generally accepted unified methods: thiobarbituric acid reactive substances (TBARS) [10], 
diene conjugates (DC) [11], and reduced glutathione (GSH) [12] content; and superoxide dis-
mutase (SOD) [13], glutathione peroxidase (Gpx) [14], and catalase (CAT) [15] activities. 
Protein content in liver homogenate was determined with accordance with Lowry’s method 
in Miller modification [16].
All procedures and euthanasia were carried out in compliance with the principles of the 
«European Convention for the Protection of Vertebrate Animals Used for Experimental and Sci-
entific Purposes» (Strasbourg, 1986) and were approved by the National University of Pharmacy 
Bioethics Commission, Protocol No. 1, 2 October 2019. 
Statistical assessment all data are reported as mean ± SEM and were analyzed using STATIS-
TICA 6 software with one-way ANOVA. P values less than 0.05 was assumed statistically significant.
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3. Results
Current results are the part of the complex experiment; thus, the data proved the IR deve-
lopment have been already published [17]. Long-term administration of dex was accompanied by 
hyperglycemia and IR development. For the IR verification, the НОМА index was determined. 
Animals that had HOMA index higher than 3,5 were believed to confirm IR. 
Long-term dex intraperitoneally administration led to an increase in aminotransferases 
overall activity in the liver homogenate and serum (Tables 1, 2). Increased activity of enzymes in 
serum, ALT by 2.5 times and AST by 1.9 times, could be the result of increased permeability of 
hepatocyte plasma membranes, which also indicated by an increase of GGT activity by 1.4 times, 
as well as their enhanced synthesis in the liver.
Table 1











IC 1.28 ± 0.04 0.46 ± 0.03 1.51 ± 0.02 259 ± 83 4.13 ± 0.07
Dex 3.27 ± 0.05* 1.13 ± 0.03* 2.64 ± 0.07* 463 ± 67* 7.14 ± 0.09*
Dex_PE50 2.5 ± 0.06 0.75 ± 0.07 1.82 ± 0.06 321 ± 42 6.11 ± 0.12
Dex_PE50_arg 1.72 ± 0.02# 0.58 ± 0.02# 1.59 ± 0.05# 273 ± 55# 4.23 ± 0.09#
Dex_arg 2.29 ± 0.04 0.87 ± 0.06 1.85 ± 0.07 307 ± 63 5.93 ± 0.11
Dex_arph 1.54 ± 0.05# 0.65 ± 0.05# 1.42 ± 0.08# 265 ± 91# 4.45 ± 0.13#
Dex_met 2.68 ± 0.06 0.98 ± 0.07 1.95 ± 0.11# 331 ± 37 6.17 ± 0.11
Note: each value represents the mean ± standard error of (n = 6); * – indicates significant difference relative to IC group (р ≤ 0.05); 
# – indicates significant difference relative to Dex group (р ≤ 0.05)
Table 2














IC 3.32 ± 0.02 1.31 ± 0.11 0.60 ± 0.03 104 ± 13 4.38 ± 1.47
Dex 4.86 ± 0.07* 2.61 ± 0.03* 0.84 ± 0.03* 59 ± 7* 8.93 ± 1.80*
Dex_PE50 4.62 ± 0.13 2.47 ± 0.11 0.75 ± 0.04 75 ± 9 7.31 ± 1.53
Dex_PE50_arg 4.56 ± 0.03# 2.34 ± 0.09# 0.62 ± 0.02# 94 ± 6# 5.74 ± 1.66#
Dex_arg 4.24 ± 0.11 2.22 ± 0.12 0.78 ± 0.07 83 ± 11 6.03 ± 1.47
Dex_arph 3.79 ± 0.09 2.07 ± 0.08 0.57 ± 0.11 97 ± 12 7.05 ± 1.24
Dex_met 4.33 ± 0.18 2.580.14 0.81 ± 0.06 75 ± 8 4.47 ± 0.93
Note: each value represents the mean ± standard error of (n = 6); * – indicates significant difference relative to IC group (р ≤ 0.05); 
# – indicates significant difference relative to Dex group(р ≤ 0.05)
Under these conditions, the total glycogen content in the liver tissue decreases by 47 %, and 
the lactate level in the blood serum increases by 72 % (Tables 1, 2). The effect of dex injections on 
glycogen level depends on the dose and terms of administration. In the initial stage, dex stimulates 
the glycogen accumulation in response to increased gluconeogenesis. However, later, according to 
the literature, the glycogen level begins to diminish gradually [18]. 
PE50_arg administration to IR rats resulted in a significant reduction in blood LDH, AST 
and ALT activities and a concomitant increase in the glycogen level in the liver (Table 2). Regard-
ing the study of liver homogenate, Table 3 shows the changes in the activities of hepatic enzymes of 
antioxidant defense SOD, CAT and GPx in IC and experimental rats injected dex. The activities of 
mentioned enzymes were increased while the content of TBARS and DC increased in dex-treated 
IR rats as compared to IC rats. Administration of PE50_arg increased the GSH level and activity of 
GPx, SOD and CAT and decreased the level of TBARS and DC by 1,71 and 1,6 times respectively as 
compared to IR rats and the effect was more pronounced in the group of rats administered with Arph.
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Table 3
















IC 2.37 ± 0.25 1.23 ± 0.13 9.14 ± 0.93 0.325 ± 0.009 0.527 ± 0.009 0.832 ± 0.003
Dex 8.49 ± 0.56 3.35 ± 0.47 5.38 ± 0.57 0.187 ± 0.011 0.334 ± 0.011 0.294 ± 0.002
Dex_PE50 6.57 ± 0.37 2.37 ± 0.21 6.99 ± 0.63 0.215 ± 0.002 0.392 ± 0.012 0.593 ± 0.011
Dex_PE50_arg 5.21 ± 0.38# 2.07 ± 0.19# 5.84 ± 0.49# 0.293 ± 0.007# 0.453 ± 0.007# 0.728 ± 0.014#
Dex_arg 6.38 ± 0.5 2.57 ± 0.2 7.11 ± 0.95 0.199 ± 0.006 0.385 ± 0.011 0,693 ± 0.011
Dex_arph 6.31 ± 0.45 2.45 ± 0.28 5.64 ± 0.79 0.307 ± 0.012 0.467 ± 0.007 0.735 ± 0.009
Dex_met 6.73 ± 0.52 2.29 ± 0.21 6.57 ± 0.84 0.225 ± 0.008 0.395 ± 0.009 0.624 ± 0.,013
Note: each value represents the mean ± standard error of (n = 6); * – indicates significant difference relative to IC group (р ≤ 0.05); 
# – indicates significant difference relative to Dex group (р ≤ 0.05)
4. Discussion
It is known that the role of the liver is one of the leading among individual organs and tis-
sues, in maintaining the acid-base balance of the blood. Liver cells utilize lactate and, when the 
lactate dehydrogenase reaction is involved, transform it into pyruvate, which is then involved in 
gluconeogenesis [19]. In our opinion, the increase in lactate levels is a consequence of disruption 
of metabolic processes in cells, transport processes in the plasma membranes of hepatocytes and 
increased permeability of plasma membranes. It is known that long-term administration of gluco-
corticoids of synthetic or natural origin causes the development of oxidative stress, the formation 
of ROS and, consequently, the lipid peroxidation (LP) intensification [20]. In our experiments, this 
is evidenced by the increase in primary (DC) and final (TBARS) products of LP (Table 3). Long-
term LP activation leads to the depletion of cell antioxidant system inner resources. Specifically, 
GSH content decrease by 1.69 times was find; moreover, it was accompanied by lowering activity 
of the antioxidant protection first line main enzymes. Thus, as SOD and CAT activities decreased 
by 1.6 times and 2.8 times respectively (Table 3). CAT activity substantial reduction compared to 
SOD activity may be mediated by raised H2O2 molecules intracellular generation because of pro-
tein kinases ASK-1 and JNK phosphorylation, which, in turn, affect the mitochondrial metabolism 
and induce the H2O2 formation [21].
Plant polyphenols of different origin, which exhibit a wide range of pharmacological effects, 
are currently widely used to correct the metabolic disorders that could be caused by dex and lead to 
the IR development [22, 23]. However, the use of some polyphenolic extracts has a positive effect 
but does not always completely improve the harmful consequences from dex administration [23].
Treatment of the experimental animals with PE50_arg under the long-term dex administra-
tion was accompanied by the significant reduction in TBARS and DC content and increase in the 
GSH level in liver homogenate (Table 3), which is, foremost, mediated by the polyphenol presence 
in the extract [24]. At the same time, arginine induces the synthesis of antioxidant defence enzymes 
mRNA, including Cu/Zn-SOD, Mn-SOD, and GPx [25]. LP processes inhibition and oxidative 
stress suppression have a positive effect on the integrity of the hepatocyte cell membranes. As can 
be seen from Table 1, under these experimental conditions, there is a significant decrease in the 
activity of the main markers of hepatocyte cytolysis in the blood serum of rats. 
The plant polyphenols administration combined with arginine trigger glycogen synthesis 
growing its content in the liver parenchyma (Table 2). The observed effect can be mediated by the 
activation of protein kinase B (Akt) and glycogen synthase kinase 3α/β (GSK3α/β) [26]. Dietary 
arginine inhibits gluconeogenesis, however, stimulates the transport of glucose into the cell [26], 
which process produces the necessary conditions for normal glycogen levels renovation (Table 2).
The blood serum lactate level reduction is an important link in the prevention of the acid- 
base balance disorders in the animals’ body. Surely, the liver plays the leading role in this process 
since hepatocytes absorb lactate from the blood and use it for glucose synthesis [26]. With high 
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probability we can assume that arginine supplementation has an impact on lactate content decrease 
in rats’ blood via arginine-nitric oxide (NO) pathway activation in muscle and endothelial cells [27] 
by stimulation of lactate absorption by muscle cells and its further utilization.
Study limitations. The experiment did not include study of ascorbate induced lipid peroxi-
dation and tocopherol content in liver homogenate. 
Prospects for further research. Further study of the effects on organs and systems of the 
bearberry leaves extract enriched with arginine to create a dietary supplement for complex treat-
ment and prophylaxis of diabetes mellitus type 2.
5. Conclusions
Low-dose dexamethasone injections led to IR development that negatively affected hepato-
cyte functions and, consequently, caused liver injury and metabolic process disorders. Bearberry 
leaves dry extract enriched with arginine inhibit oxidative stress development, improve membrane 
integrity, and normalize some indices of carbohydrate metabolism, particularly glycogen content 
in liver and lactate level in blood. We suggest that hepatoprotective effect is mediated by the anti-
oxidant action of plant polyphenols from PE50_arg composition and, moreover, the arginine sup-
plementation ameliorated this effect.
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